Made in India : The Story of Desh Bandhu Gupta,Lupin and Indian Pharma

From Village Classroom to $10 Billion Pharmaceutical EmpireWhat does it take to rise from a humble professor in Rajasthan to building one of India's most influential pharmaceutical companies—reaching over 120 countries and fundamentally changing how the world accesses affordable medicine? This is the untold story of Desh Bandhu Gupta, Lupin, and how India became the pharmacy to the world.The Transformation Nobody ExpectedIn a country suffocated by the License Raj, where foreign multinationals dominated and entrepreneurship was an act of rebellion, a soft-spoken teacher dared to dream differently. Desh Bandhu Gupta had no family wealth, no business pedigree, no powerful connections. What he had was an unshakeable conviction that Indians could build world-class institutions—and that affordable medicine was a fundamental right, not a luxury. Inside This Book, You'll Discover:-The Unlikely Beginning: How a village boy from Rajasthan became a teacher, then a professor, before abandoning security to enter the cutthroat pharmaceutical industry—against every rational instinct-Building Against the Odds: The financial crises, near-bankruptcies, regulatory nightmares, and crushing setbacks that nearly destroyed Lupin before it could fly—and the resilience that rebuilt it each time-The Contribution of Manju Gupta (Desh Bandhu Gupta’s Wife): The pivotal, often-overlooked role of Manju Gupta in building not just a company but a legacy of community service and rural transformation alongside her husband-India's Pharma Titans: How seven visionary entrepreneurs—Yusuf Hamied (Cipla), Anji Reddy (Dr. Reddy's), Dilip Shanghvi (Sun Pharma), Parvinder Singh (Ranbaxy), and DBG (Lupin)—collectively demolished the myth that Indian companies couldn't compete globally-From Dependency to Dominance: How India went from importing nearly all its medicines to manufacturing 50% of America's pills, 60% of the world's vaccines, and operating a third of all FDA-approved factories selling to the US-The